Zhongfeng Xingnao Granules

Zhongfeng Xingnao Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine for the treatment of acute cerebral hemorrhage. Based on the therapeutic principle of 'supplementing Qi and activating blood circulation' (Yiqi Huoxue), the granules are intended to reduce mortality and improve neurological recovery in patients during the acute phase of hemorrhagic stroke. The formulation typically includes a combination of herbs such as Astragalus and Panax notoginseng, which are traditionally used to address the underlying TCM patterns of Qi deficiency and blood stasis associated with cerebrovascular events. As a hospital-made preparation, it is primarily utilized within the clinical setting of its developing institution and has been the subject of interventional clinical studies to evaluate its efficacy and safety in stroke management.

Other names

Zhongfeng Xingnao Keli